Clinical Oncology - Issue Supplementum 1/2022
126
Article
132
MicroRNAs as potential prognostic and predictive biomarkers in patients with atypical meningioma
D. Al Tukmachi, O. Naar, P. Fadrus, V. Vybíhal, O. Slabý, J. Šána
135
Pilot analysis of the PD-L1 expression in ovarian cancer patients treated with platinum-based chemotherapy
J. Hausnerová, L. Ehrlichová, P. Ovesná, E. Gazárková, J. Chlubnová, K. Matulová, Luboš Minář, Vít Weinberger, Markéta Bednaříková
138
Sequencing of long non-coding RNAs in exosomes of colorectal cancer patients
M. Madrzyk, T. Macháčková, K. Trachtová, T. Catela Ivković, K. Součková, J. Kotouček, J. Mašek, T. Loja, M. Šachlová, O. Slabý
142
Targeted RNA sequencing-based fusion gene analysis as a tool for diagnostics and therapeutic planning in pediatric cancer patients with solid tumors
P. Pokorná, D. Al Tukmachi, K. Trachtová, H. Pálová, S. Adamcová, K. Koželková, P. Múdrý, Z. Pavelka, J. Štěrba, O. Slabý
145
Sequencing of microRNAs in brain metastases as a new diagnostic tool
M. Večeřa, L. Radová, F. Siegl, M. Smrčka, R. Jančálek, M. Hermanová, M. Hendrych, L. Křen, J. Šána, O. Slabý
148
Retrospective study of patients with tubo-ovarian cancers (n = 510) and an analysis of main factors influencing PFS and OS – the experience of a comprehensive oncology center during 2010–2019
S. Vokurka, M. Ambrožová, O. Ngo, V. Vaněček, O. Fiala, M. Votavová, O. Hes, Jiří Presl, J. Ferda, J. Fínek
Clinical Oncology
2022 Číslo Supplementum 1
Najčítanejšie v tomto čísle
- VIII. Radioterapeutické metody a radiofarmaka
- Pilot analysis of the PD-L1 expression in ovarian cancer patients treated with platinum-based chemotherapy
- XXII. Nádory slinivky, jater a žlučových cest
- XXVIII. Neuroendokrinní a endokrinní nádory